JPS6416716A - Production of emulsion pharmaceutical containing sparingly soluble drug sealed therein - Google Patents

Production of emulsion pharmaceutical containing sparingly soluble drug sealed therein

Info

Publication number
JPS6416716A
JPS6416716A JP17294087A JP17294087A JPS6416716A JP S6416716 A JPS6416716 A JP S6416716A JP 17294087 A JP17294087 A JP 17294087A JP 17294087 A JP17294087 A JP 17294087A JP S6416716 A JPS6416716 A JP S6416716A
Authority
JP
Japan
Prior art keywords
sparingly soluble
phospholipid
soluble drug
oily ingredient
vol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP17294087A
Other languages
Japanese (ja)
Other versions
JP2543708B2 (en
Inventor
Tomokazu Sugi
Nobuyuki Suzuki
Hiroshi Kawamichi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd filed Critical Asahi Chemical Industry Co Ltd
Priority to JP62172940A priority Critical patent/JP2543708B2/en
Publication of JPS6416716A publication Critical patent/JPS6416716A/en
Application granted granted Critical
Publication of JP2543708B2 publication Critical patent/JP2543708B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE:To obtain a pharmaceutical, forming a fine emulsion and capable of being parenterally, especially intraveously administered, by kneading a sparingly soluble drug with an oily ingredient in the coexistence of a phospholipid, adding an aqueous solution and emulsifying the resultant kneaded blend. CONSTITUTION:A sparingly soluble drug hardly soluble in water and oils is sufficiently kneaded and blended with an adequate amount of an oily ingredient (preferably an oil, derived from a plant and purified to a high purity) and a phospholipid to form a homogeneous dispersion system, which is then mixed with a solution prepared by dissolving the residual phospholipid in the residual oily ingredient while heating and homogenized using a homomixer. An aqueous solution containing required additives, such as emulsification adjuvant, isotonizing agent, antioxidant, dissolved therein is then added to emulsify the obtained blend and afford the aimed emulsion pharmaceutical. The above- mentioned pharmaceutical preferably consists of 0.001-30wt./vol.% sparingly soluble drug, 1-30wt./vol.%, especially 5-20wt./vol.% oily ingredient, the phospholipid in an amount of 1-50pts.wt., especially 5-35pts.wt. based on 100pts.wt. oily ingredient and water in an adequate amount.
JP62172940A 1987-07-13 1987-07-13 Method for producing emulsion formulation encapsulating poorly soluble drug Expired - Fee Related JP2543708B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62172940A JP2543708B2 (en) 1987-07-13 1987-07-13 Method for producing emulsion formulation encapsulating poorly soluble drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62172940A JP2543708B2 (en) 1987-07-13 1987-07-13 Method for producing emulsion formulation encapsulating poorly soluble drug

Publications (2)

Publication Number Publication Date
JPS6416716A true JPS6416716A (en) 1989-01-20
JP2543708B2 JP2543708B2 (en) 1996-10-16

Family

ID=15951168

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62172940A Expired - Fee Related JP2543708B2 (en) 1987-07-13 1987-07-13 Method for producing emulsion formulation encapsulating poorly soluble drug

Country Status (1)

Country Link
JP (1) JP2543708B2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004886A1 (en) * 1990-09-26 1992-04-02 Meito Sangyo Co., Ltd. Fat emulsion for intravenous injection
WO1992007571A1 (en) * 1990-11-06 1992-05-14 Nippon Shinyaku Co., Ltd. Process for producing fat emulsion
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
US20120009250A1 (en) * 2003-11-11 2012-01-12 Claudia Mattern Controlled release delivery system for nasal applications
US8609043B2 (en) 2004-12-28 2013-12-17 M & P Patent Aktiengesellschaft Use of a container of an inorganic additive containing plastic material
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
US9186320B2 (en) 2006-10-04 2015-11-17 Mattern Pharma Ag Controlled release delivery system for nasal application of neurotransmitters
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US10111888B2 (en) 2011-05-13 2018-10-30 Acerus Biopharma Inc. Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US10668084B2 (en) 2011-05-13 2020-06-02 Acerus Biopharma Inc. Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11090312B2 (en) 2013-03-15 2021-08-17 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2890643B2 (en) 1990-03-31 1999-05-17 スズキ株式会社 Outboard motor
US20070196436A1 (en) * 2006-02-23 2007-08-23 Conopco, Inc., D/B/A Unilever Process for preparing an edible composition comprising steroidal glycosides

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004886A1 (en) * 1990-09-26 1992-04-02 Meito Sangyo Co., Ltd. Fat emulsion for intravenous injection
WO1992007571A1 (en) * 1990-11-06 1992-05-14 Nippon Shinyaku Co., Ltd. Process for producing fat emulsion
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
US8784882B2 (en) * 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and method of treatment
US9238072B2 (en) 2003-11-11 2016-01-19 Mattern Pharma Ag Controlled release delivery system for nasal applications and method of treatment
US8574622B2 (en) * 2003-11-11 2013-11-05 M & P Patent Aktiengesellschaft Controlled release delivery system for nasal applications
US9962394B2 (en) 2003-11-11 2018-05-08 M et P Pharma AG Controlled release delivery system for nasal applications and method of treatment
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
US20120009250A1 (en) * 2003-11-11 2012-01-12 Claudia Mattern Controlled release delivery system for nasal applications
US9579280B2 (en) 2003-11-11 2017-02-28 Mattern Pharma Ag Controlled release delivery system for nasal applications and method of treatment
US20120058176A1 (en) * 2003-11-11 2012-03-08 Claudia Mattern Controlled release delivery system for nasal applications and method of treatment
US8609043B2 (en) 2004-12-28 2013-12-17 M & P Patent Aktiengesellschaft Use of a container of an inorganic additive containing plastic material
US9186320B2 (en) 2006-10-04 2015-11-17 Mattern Pharma Ag Controlled release delivery system for nasal application of neurotransmitters
US9801834B2 (en) 2006-10-04 2017-10-31 M et P Pharma AG Controlled release delivery system for nasal application of neurotransmitters
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US10111888B2 (en) 2011-05-13 2018-10-30 Acerus Biopharma Inc. Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US10668084B2 (en) 2011-05-13 2020-06-02 Acerus Biopharma Inc. Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11090312B2 (en) 2013-03-15 2021-08-17 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event

Also Published As

Publication number Publication date
JP2543708B2 (en) 1996-10-16

Similar Documents

Publication Publication Date Title
JPS6416716A (en) Production of emulsion pharmaceutical containing sparingly soluble drug sealed therein
AU567271B2 (en) Lyophilization of oil in water emulsion to give galenic form for oral administration
EP0100459B1 (en) An aqueous liquid containing a fat-soluble substance
KR870002834A (en) Manufacturing method of emulsion composition
CA2347118A1 (en) Propofol composition comprising pentetate
JPH0336567B2 (en)
JPS6025918A (en) Aqueous solution containing fat-soluble drug
JPS6139924B2 (en)
KR960016890A (en) Intravenous solution of staurosporin derivative
JPS5793910A (en) Preparation of emulsion for intravenous injection
JPS6245336A (en) Emulsified composition
CN100384436C (en) Parenteral cisplatin emulsion
JPS58162517A (en) Fat-soluble vitamin-containing fatty emulsion
CN102370619A (en) Fat-emulsion-emulsified local anesthetic
JP2779236B2 (en) Water-dispersible lecithin
JPH01143826A (en) Fat emulsion of fine particle
JPS58164508A (en) Composition for external use containing isoprenyl-carboxylic acid
JP2000119686A (en) Powdery oil and fat composition and preparation thereof
JPS6416727A (en) Novel medical preparation of ara-c derivative
JPH0648939A (en) Skin external preparation containing sodium diclofenac
EP0331948B1 (en) Pharmaceutical composition for the transdermal administration of heparin
JPH01113315A (en) Fat emulsion containing vitamin k2
JPS57136511A (en) Preparation of ointment base containing silicone oil with high concentration
JPH0399010A (en) Pharmaceutical composition
JPS62175414A (en) Emulsion cosmetic

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees